Swedish Orphan Biovitrum - PDFSEARCH.IO - Document Search Engine

Swedish Orphan Biovitrum
Results: 8

#	Item
1	Corporate Presentation April 2015 Forward-looking statements This document does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any Add to Reading List Source URL: www.tigenix.com Language: English - Date: 2015-04-23 07:59:35 Biotechnology Cloning Cell therapy Emerging technologies Peripheral blood mononuclear cell Mesenchymal stem cell Swedish Orphan Biovitrum Tissue engineering Pharmaceutical industry Biology Stem cells Cell biology
2	TiGenix Investment highlights An advanced biopharmaceutical company focused on developing and commercialising Add to Reading List Source URL: www.tigenix.com Language: English - Date: 2015-04-23 08:03:15 Stem cells Cell biology Cell therapy Swedish Orphan Biovitrum Adipose tissue Stem cell Pharmaceutical industry Biologic Biopharmaceutical Biology Biotechnology Pharmacology
3	ANNUAL REPORTWe’ve got a story to tell 1 The financial year in brief Add to Reading List Source URL: www.sobi.com Language: English - Date: 2015-04-14 10:40:54 Biology Medicine Swedish Orphan Biovitrum Biogen Idec Factor VIII Factor IX Pfizer Coagulation Haemophilia Coagulation system Anatomy
4	cabozantinib 20mg and 80mg hard capsules (Cometriq®) Swedish Orphan Biovitrum Ltd. SMC No[removed]February 2015 Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English Oncology Organofluorides Medullary thyroid cancer Cabozantinib Vandetanib Thyroid neoplasm Multiple endocrine neoplasia End point of clinical trials Metastasis Medicine Thyroid cancer Chemistry
5	Q2 2014 Pioneer in Rare Diseases Financial Calendar Add to Reading List Source URL: www.sobi.com Language: English - Date: 2014-07-18 01:28:38 Swedish Orphan Biovitrum Biogen Idec IDEC Income statement EBITA Revenue Haemophilia Generally Accepted Accounting Principles Business
6	REPORT FOR THE FIRST QUARTER • 2013 Pioneer in Rare Diseases SOBI REPORT FOR THE FIRST QUARTER \|TABLE OF CONTENTS 1 Add to Reading List Source URL: www.sobi.com Language: English - Date: 2013-11-21 07:49:43 Finance Swedish Orphan Biovitrum Anakinra ICA AB Amgen Income statement EBITA Gross margin Haemophilia Generally Accepted Accounting Principles Business
7	Q3 Pioneer in Rare Diseases Report for the Third Quarter 2013 SOBI \|CEO STATEMENT 1 Add to Reading List Source URL: www.sobi.com Language: English - Date: 2013-11-21 07:49:54 Generally Accepted Accounting Principles Amgen Thousand Oaks California Anakinra Swedish Orphan Biovitrum Income statement International Financial Reporting Standards Investor AB Revenue Business Accountancy Finance
8	Q2 Pioneer in Rare Diseases Report for the Second Quarter 2013 SOBI REPORT FOR THE SECOND QUARTER \|CEO STATEMENT 1 Add to Reading List Source URL: www.sobi.com Language: English - Date: 2013-11-21 07:49:24 Swedish Orphan Biovitrum Investor AB IDEC Financial ratio Business Biogen Idec Income statement